TIFFANY WILBURN: Open Payments
NPI 1346946373 · HAZEL GREEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,500 in 122 payments from 26 companies in 2025. Trend: 2023 $1,418 · 2024 $2,270 · 2025 $2,500
Food & beverage: $2,500
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $414 |
| AstraZeneca Pharmaceuticals LP | 18 | $406 |
| Novo Nordisk Inc | 23 | $333 |
| Lilly USA, LLC | 8 | $145 |
| Antares Pharma, Inc. | 7 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $116 |
| Lundbeck LLC | 5 | $104 |
| Ardelyx, Inc. | 5 | $96 |
| ABBVIE INC. | 4 | $95 |
| Corcept Therapeutics | 4 | $87 |
Products named: CAPLYTA, AIRSUPRA, Ozempic, FARXIGA, XYOSTED, Wegovy, TRINTELLIX, MOUNJARO.
Industry payments across AL — which companies pay providers there.
